FDA panel calls for easing restrictions on testosterone replacement therapy for men
Regulatory NewsJoanne S. Eglovitch
Advertising, Promotion and LabelingAdvisory committeesPharmaceuticalsRegulatory Intelligence/PolicyRegulatory strategyUnited StatesUS Food and Drug Administration (FDA)